top of page
Untitled (1920 x 1004 px).png

Nonclinical Safety and Toxicology Consulting

make your breakthrough a reality

Scientist on Computer

Accelerate Your Therapeutic Success with Expert Nonclinical Safety Consulting

From discovery to the clinic, Toxistrategy delivers tailored nonclinical safety solutions to meet your program's unique challenges. Whether navigating toxicology strategy, IND-enabling packages or regulatory authoring, we provide unmatched
expertise to ensure your therapeutic reaches its full potential.

SERVICES

Transgenic Animals

Nonclinical Safety + Toxicology

Nonclinical development of assets from discovery to clinic, including overall toxicology strategy, study execution, management, and reporting.

Experts Panel

Regulatory Oversight

Strategic planning, timeline coordination and authoring of regulatory documents, including INDs, CTAs, IBs, BBs, and more.

Data on a Touch Pad

SEND Datasets

Oversight of SEND datasets including dataset requirements, review and submission.

WHO WE ARE

Dessi McEntee, MS, DABT

Owner & Consultant

  • LinkedIn

Dessi is a board-certified toxicologist whose unique combination of expertise puts her in the top 1% of nonclinical safety professionals in the industry. She has amassed over a decade of extensive experience in the exploratory and GLP nonclinical sciences of the pharmaceutical and biotech industries, and has championed the advancement of numerous critical medicines to the clinic through successful leadership of Toxicology, Safety Pharmacology and DART strategies related to both small and large molecule therapeutics. Dessi has been the toxicologist at numerous different startups and is batting a thousand in regulatory submissions.

​

Toxistrategy is a one-woman operation. Instead of a team of consultants trying to stretch the hours for more money, you get a personalized, high touch consultant who will not only meet your expectations but exceed them. I will make your breakthrough a reality.

Untitled design (35) (1).png

TESTIMONIALS

"I have worked closely with Dessi for many years, both at small molecule and protein biologics companies. What has impressed me the most about her skill sets and experiences is that she is very diligent in not only designing the studies, executing them to the highest standards but she also makes a concerted effort to understand the science behind the programs she has been involved with. In an area that seems to be changing in the requirements for nonclinical safety and drug development, Dessi is extremely up-to-date on this morphing landscape. This has been comforting for me and my teams in that we know that she will ensure compliance with the changing times. Even after our times together at the same organizations I continue to reach out and recommend Dessi as my go-to nonclinical colleague. Besides her immense knowledge base in the areas of safety and nonclinical drug development, Dessi is one of the kindest, hard-working individuals I know and would be a benefit to any organization/team. I have worked with Dessi for years and look forward to continuing any opportunity where we can work together again."

Principal at TranslationalBio LLC

bottom of page